Abstract
Özet: Covid 19 pandemisi Çin’in Wuhan kentinde ortaya çıkmış ve tüm dünyaya hızla yayılmıştır. Covid 19 nedeniyle takip edilen hastalar, fırsatçı mantar enfeksiyonları için risk faktörlerine sahip olmalarına rağmen bu konuyla ilgili literatür sınırlı sayıdadır. Covid -19’lu hastalarımızdan kandida enfeksiyonu saptadığımız 4 olgunun özelliklerini konuya dikkat çekmek için sunmayı amaçladık
Supporting Institution
yok
Project Number
yok
Thanks
yok
References
- Referans 1-.Salehi M, Ahmadikia K, Badali H, Khodavaisy S.Opportunistic Fungal Infections in the Epidemic Area of COVID-19: A Clinical and Diagnostic Perspective from Iran. Mycopathologia. 2020; 185:607–611.
- Referans 2- T.C Sağlık Bakanlığı Covid Rehberi
- Referans 3- Gangneux J-P, Bougnoux M-E, Dannaoui E, Cornet M,Ralph ZJ. Invasive fungal diseases during COVID-19: we should be prepared. J Mycol Med. 2020;30(2):100971
- Referans 4- Ceballos-Salobren˜a A, Gaita´n-Cepeda LA, Ceballos-GarciaL, Lezama-Del VD. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS? AIDS Patient Care and STDs. 2000;14(12):627–35
- Referans 5-Akpan A, Morgan R. Oral candidiasis. Postgrad Med J. 2002;78(922):455-459
- Referans 6- Salehi M, Ahmadikia K, Mahmoudi S et al.Oropharyngeal candidiasis in hospitalized COVID‐19 Patients from Iran: Species identification and antifungal susceptibility pattern Mycoses. 2020 ;63(8): 771–8.
- Referans 7-Cornistein W, Mora A, Orellana N, Capparelli FJ, del Castillo M. Candida: epidemiology and risk factors for non-albicans species. Enferm Infecc Microbiol Clin. 2013;31(6):380-4.
Abstract
Abstract: The coronavirus disease 2019 (COVID- 19) pandemic emerged in Wuhan, China, and has rapidly spread around the world. Although patients followed up for Covid 19 have risk factors for opportunistic fungal infections, the literature on this issue is limited. We aimed to present the characteristics of four patients in which we detected candida infection from our patients with Covid-19 to draw attention in this issue.
Project Number
yok
References
- Referans 1-.Salehi M, Ahmadikia K, Badali H, Khodavaisy S.Opportunistic Fungal Infections in the Epidemic Area of COVID-19: A Clinical and Diagnostic Perspective from Iran. Mycopathologia. 2020; 185:607–611.
- Referans 2- T.C Sağlık Bakanlığı Covid Rehberi
- Referans 3- Gangneux J-P, Bougnoux M-E, Dannaoui E, Cornet M,Ralph ZJ. Invasive fungal diseases during COVID-19: we should be prepared. J Mycol Med. 2020;30(2):100971
- Referans 4- Ceballos-Salobren˜a A, Gaita´n-Cepeda LA, Ceballos-GarciaL, Lezama-Del VD. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS? AIDS Patient Care and STDs. 2000;14(12):627–35
- Referans 5-Akpan A, Morgan R. Oral candidiasis. Postgrad Med J. 2002;78(922):455-459
- Referans 6- Salehi M, Ahmadikia K, Mahmoudi S et al.Oropharyngeal candidiasis in hospitalized COVID‐19 Patients from Iran: Species identification and antifungal susceptibility pattern Mycoses. 2020 ;63(8): 771–8.
- Referans 7-Cornistein W, Mora A, Orellana N, Capparelli FJ, del Castillo M. Candida: epidemiology and risk factors for non-albicans species. Enferm Infecc Microbiol Clin. 2013;31(6):380-4.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Clinical Sciences |
| Journal Section | Case Report |
| Authors | |
| Project Number | yok |
| Early Pub Date | January 15, 2024 |
| Publication Date | January 1, 2024 |
| Submission Date | December 20, 2021 |
| Published in Issue | Year 2024 |